Mahboob Vaseem Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$418,217.22

Insider Activity of Mahboob Vaseem

According to the SEC Form 4 filings, Mahboob Vaseem, being in a position of

  1. Chief Financial Officer at Kestra Medical Technologies, Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 130970 shares for $3.68M,
    over all time since 2026-07-30, has bought 0 shares, and sold 130970 shares for $3.68M.

Biography of Mahboob Vaseem

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,679,8258100

Comparison of Insiders on Amount of Buys and Sells

2026-10-29SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
4,788
0.008%
$30.60$146,503-3.01%
2026-10-28SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
39,903
0.0684%
$30.48$1.22M-0.4%
2026-10-27SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
34,809
0.0585%
$30.04$1.05M-0.6%
2026-08-07SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
26,287
0.0441%
$25.88$680,383+2.65%
2026-08-04SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
6,995
0.0114%
$24.68$172,635+4.07%
2026-08-03SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
5,391
0.0092%
$23.80$128,312+12.46%
2026-07-31SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
8,817
0.015%
$22.61$199,344+18.16%
2026-07-30SaleKestra Medical Technologies, Ltd.
KMTS
Chief Financial Officer
3,980
0.0067%
$22.75$90,561+16.5%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.